Wednesday Product Theatre (Non-CE): Advancing the Practice of Treating Vaginal Yeast Infections

20th Annual NPWH Premier Women's Healthcare Conference

CE

Mark Martens MD, FACOG

Candida resistance and recurrence are increasing and non-albicans species of yeast are becoming more prevalent and difficult to treat. Our 2017 symposium features information about the range of treatments for vulvovaginal candidiasis (VVC), with focus on providing up to date information on recent evidence-based treatment guidance including:  

  • Empiric treatment of vaginal yeast infection
  • Treatment of VVC by species of yeast
  • Evidence based recommendations from the CDC and the International Society for the Study of Vulvovaginal Disease (ISSVD)

The increasing trend toward resistance is concerning, yet options exist to reduce the impact.  Join us as we discuss this common condition!